Who
Rebecca Byam
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, HCW Biologics.
In numbers
- Trades disclosed
- 45
- Buys
- 32
- Sells
- 0
- Bought
- $1.5M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Jul 2021
- Last trade
- 22 May 2026
- Last filed
- 27 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 May 2026filed 27 May 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $20K14,235 at $1.41 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —14,235 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —14,235 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $20K14,235 at $1.41 | filing |
| 8 May 2025filed 9 May 2025 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $220K8,462 at $26.00 | filing |
| 7 May 2025filed 9 May 2025 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —4,231 at $0.00 | filing |
| 20 Feb 2024filed 22 Feb 2024 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Code A | $1.1M760,714 at $1.40 | filing |
| 19 Oct 2023filed 23 Oct 2023 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —47,249 at $0.00 | filing |
| 19 Oct 2023filed 23 Oct 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Code M | $6,61547,249 at $0.14 | filing |
| 13 Sep 2023filed 15 Sep 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $11K5,000 at $2.10 | filing |
| 12 Sep 2023filed 13 Sep 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $10K5,000 at $2.09 | filing |
| 11 Sep 2023filed 13 Sep 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $10K5,000 at $2.05 | filing |
| 8 Sep 2023filed 8 Sep 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $10K5,000 at $2.02 | filing |
| 7 Sep 2023filed 8 Sep 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $9,7505,000 at $1.95 | filing |
| 6 Sep 2023filed 7 Sep 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $9,7505,000 at $1.95 | filing |
| 9 Jun 2023filed 9 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $41K20,000 at $2.06 | filing |
| 8 Jun 2023filed 8 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $10K4,696 at $2.21 | filing |
| 7 Jun 2023filed 8 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $41K20,000 at $2.03 | filing |
| 6 Jun 2023filed 7 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $35K19,062 at $1.82 | filing |
| 5 Jun 2023filed 7 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $33K20,000 at $1.67 | filing |
News
Financial Survey: HCW Biologics (NASDAQ:HCWB) vs. Cardio Diagnostics (NASDAQ:CDIO)HCWB · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Rebecca Byam; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.